Mixed Epithelial and Germ Cell Ovarian Cancer: A Case Report

Crossmark: check for updates

Authors

  • Margaret Storm, Hanna G. Kaspar Geisinger Medical Center, Danville, PA 17837, USA
  • John D. Nash Geisinger Medical Center, Danville, PA 17837, USA
  • Radhika Gogoi Geisinger Medical Center, Danville, PA 17837, USA
  • Ashlee L. Smith Geisinger Medical Center, Danville, PA 17837, USA

DOI:

https://doi.org/10.17140/WHOJ-1-107

Keywords:

Mixed ovarian germ cell tumors; Cell carcinoma; Sac tumor.

Abstract

Background: Cases of malignant ovarian tumors consisting of Clear Cell Carcinoma (CCC)
and Yolk Sac Tumor (YST) are decidedly rare.
Case: We herein report the case of a 58-year-old woman with an ovarian tumor, of which approximately 70 percent was composed of CCC and 30 percent YST. The plan was to utilize a
chemotherapeutic regimen of 4 cycles of Bleomycin, Etoposide, Cisplatin (BEP) followed by
4 cycles of Carboplatin/Paclitaxel.
Conclusion: No previous cases with an identical combination of CCC and YST have been
found in the literature. Because of its rarity, deciding on optimal therapy is challenging.

References

Ohishi Y, Kaku T, Kaneki E, Wake N, Tsuneyoshi M. Malig-nant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac Women Health Open J tumor and immature teratoma with prominent neuroectoder-mal and rhabdomyosarcomatous differentiation: a case study. Gynecol Oncol. 2007; 105(2): 548-552. doi: 10.1016/j.ygy-no.2007.02.003

Ashihara T, Nakanishi K, Hashii K, et al. Ovarian yolk sac tumor in a postmenopausal woman: care report and review of literature. International Cancer Conference Journal. 2012; 1(2): 96-102.

Cicin I, Saip P, Guney N, et al. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic fac-tors. Eur J Obstet Gynecol Reprod Biol. 2009; 146(2): 210-214. doi: 10.1016/j.ejogrb.2009.02.052

Haugnes HS, Stephenson AJ, Feldman DR. Beyond stage I germ cell tumors: current status regarding treatement and long-term toxicities. Am Soc Clin Oncol Educ Book. 2014; 180-190. doi: 10.14694/EdBook_AM.2014.34.e180

Sirichaisutdhikorn D, Suprasert P, Khunamornpong S. Clini-cal outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin. Asian Pac J Cancer Prev. 2009; 10(6): 1041-1045.

Downloads

Published

2015-09-24

How to Cite

Margaret Storm, Hanna G. Kaspar, John D. Nash, Radhika Gogoi, & Ashlee L. Smith. (2015). Mixed Epithelial and Germ Cell Ovarian Cancer: A Case Report. Women’s Health, 45–47. https://doi.org/10.17140/WHOJ-1-107

Issue

Volume 1 Issue 1 2015

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Women's Health (WH) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.